The unspecific binding of CD8+ T cells to MHC multimer/tetramer has been diminished through sequence modification of HLA domains, which dramatically elevated the detection specificity of the T cells.
Creative Biolabs' T Cell-based multimer/tetramer assay is a powerful tool designed to provide you with precise, actionable data on antigen-specific T-cell populations. Inspired by the unique binding interaction between TCR and peptide-MHC, Creative Biolabs offers synthesized peptide-MHC multimer/tetramer and its application in cancer epitope analysis. Creative Biolabs provides specific deliverables, solutions, and key problem-solving capabilities to ensure you achieve your research goals.
The exquisite specificity of T cell response to peptide/MHC is useful in tracing antigen-specific T cells and analyzing antigenic peptides. But the binding affinity of a single peptide/MHC to its cognate TCR is low and dissociates quickly. Tetramerized MHC molecules loaded with candidate peptides promoted the association of TCR with the complex. When labeling with fluorescent dyes, MHC tetramer/multimer could act as a staining reagent for epitope-specific T cells, enabling the convenient detection by a flow cytometer. Class I and class II tetramer reagents are produced differently and have been used in identifying CD8+ and CD4+ T cells, respectively.
Discover how we can help - Request a consultation.
Fig.1 Self-reactive T-cells have low-affinity T-cell receptors (TCRs).1
The unspecific binding of CD8+ T cells to MHC multimer/tetramer has been diminished through sequence modification of HLA domains, which dramatically elevated the detection specificity of the T cells.
We adopt superior material for tetramer/multimer production, ensuring the high quality and efficiency of the synthesis. With the assurance of strict quality control throughout the whole production process, our MHC multimer/tetramer demonstrates a high specificity and clear discrimination of antigenic epitopes.
With a bank of over 60 types of HLA alleles, we can produce custom tetramers tailored to your specific research objectives. This extensive library ensures a perfect match for your project.
Our team's two decades of expertise in immunology and assay development ensure every project is handled with precision and scientific integrity. We are your reliable partner for achieving breakthroughs.
We go beyond standard methods by leveraging advanced staining protocols and higher-order dextramers. This enables us to reliably detect even low-affinity T-cell populations, crucial for cancer and autoimmune research.
Our streamlined project workflow, from consultation to final report, is designed for maximum efficiency. We provide timely communication and support to ensure your project progresses smoothly and on schedule.
We continuously innovate to stay ahead of scientific advancements. By incorporating emerging technologies like advanced enrichment procedures and high-multiplexing capabilities, we deliver data with unparalleled depth.
Discover how a partnership with us can streamline your research - Get a quote today.
Our assays are designed to address this challenge. We utilize higher-order multimers, such as dextramers, and advanced staining protocols to enhance binding avidity and prevent TCR internalization, ensuring that even low-affinity T-cell populations are detected.
Yes, we specialize in custom solutions. In addition to a vast library of classical MHC I and II alleles, we can develop multimers for non-classical MHC molecules and other non-MHC ligands to meet the unique needs of your research.
We offer highly sensitive T- and B-cell based ELISpot assays to assess cytokine secretion and T-cell activation at a single-cell level. This is ideal for identifying rare antigen-specific lymphocytes.
Learn More →A comprehensive platform to assess immune cell functionality. This includes services for evaluating T cell proliferation, cytokine release, cytotoxicity, and the analysis of immune cell populations through flow cytometry.
Learn More →Equipped with advanced technologies, Creative Biolabs is devoted to offering multiple T and B cell-based assays for cancer epitope analysis. We are also experienced in developing epitope-targeted immunotherapies for cancer and autoimmune diseases. If you are interested in learning more about Creative Biolabs' services, please do not hesitate to contact us for more details.
Reference